Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study

OBJECTIVE: This study was performed to compare health-related quality of life (HRQOL) of gemcitabine plus S-1 (GS), S-1 alone and gemcitabine alone as first-line chemotherapy for locally advanced or metastatic pancreatic cancer in the GEST (Gemcitabine and TS-1 Trial) study and to assess the impacts...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagiwara, Yasuhiro, Ohashi, Yasuo, Okusaka, Takuji, Ueno, Hideki, Ioka, Tatsuya, Boku, Narikazu, Egawa, Shinichi, Hatori, Takashi, Furuse, Junji, Mizumoto, Kazuhiro, Ohkawa, Shinichi, Yamaguchi, Taketo, Yamao, Kenji, Funakoshi, Akihiro, Cheng, Ann-Lii, Kihara, Kiyohiro, Sato, Atsushi, Tanaka, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESMO Open 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519786/
https://www.ncbi.nlm.nih.gov/pubmed/28761731
http://dx.doi.org/10.1136/esmoopen-2016-000151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519786/
https://www.ncbi.nlm.nih.gov/pubmed/28761731
http://dx.doi.org/10.1136/esmoopen-2016-000151

Ejemplares similares